These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23840655)

  • 1. The Glycophosphatidylinositol Anchor of the MCMV Evasin, m157, Facilitates Optimal Cell Surface Expression and Ly49 Receptor Recognition.
    Carlin LE; Guseva NV; Shey MR; Ballas ZK; Heusel JW
    PLoS One; 2013; 8(6):e67295. PubMed ID: 23840655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycosylation contributes to variability in expression of murine cytomegalovirus m157 and enhances stability of interaction with the NK-cell receptor Ly49H.
    Guseva NV; Fullenkamp CA; Naumann PW; Shey MR; Ballas ZK; Houtman JC; Forbes CA; Scalzo AA; Heusel JW
    Eur J Immunol; 2010 Sep; 40(9):2618-31. PubMed ID: 20662096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of murine cytomegalovirus m157 from infected cells and identification of critical residues mediating recognition by the NK cell receptor Ly49H.
    Davis AH; Guseva NV; Ball BL; Heusel JW
    J Immunol; 2008 Jul; 181(1):265-75. PubMed ID: 18566392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional consequences of natural sequence variation of murine cytomegalovirus m157 for Ly49 receptor specificity and NK cell activation.
    Corbett AJ; Coudert JD; Forbes CA; Scalzo AA
    J Immunol; 2011 Feb; 186(3):1713-22. PubMed ID: 21187440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A positive cooperativity binding model between Ly49 natural killer cell receptors and the viral immunoevasin m157: kinetic and thermodynamic studies.
    Romasanta PN; Curto LM; Urtasun N; Sarratea MB; Chiappini S; Miranda MV; Delfino JM; Mariuzza RA; Fernández MM; Malchiodi EL
    J Biol Chem; 2014 Feb; 289(8):5083-96. PubMed ID: 24379405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural elucidation of the m157 mouse cytomegalovirus ligand for Ly49 natural killer cell receptors.
    Adams EJ; Juo ZS; Venook RT; Boulanger MJ; Arase H; Lanier LL; Garcia KC
    Proc Natl Acad Sci U S A; 2007 Jun; 104(24):10128-33. PubMed ID: 17537914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical residues at the Ly49 natural killer receptor's homodimer interface determine functional recognition of m157, a mouse cytomegalovirus MHC class I-like protein.
    Kielczewska A; Kim HS; Lanier LL; Dimasi N; Vidal SM
    J Immunol; 2007 Jan; 178(1):369-77. PubMed ID: 17182575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gain of virulence caused by loss of a gene in murine cytomegalovirus.
    Bubić I; Wagner M; Krmpotić A; Saulig T; Kim S; Yokoyama WM; Jonjić S; Koszinowski UH
    J Virol; 2004 Jul; 78(14):7536-44. PubMed ID: 15220428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerance of NK cells encountering their viral ligand during development.
    Sun JC; Lanier LL
    J Exp Med; 2008 Aug; 205(8):1819-28. PubMed ID: 18606858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous engagement of a self-specific activation receptor induces NK cell tolerance.
    Tripathy SK; Keyel PA; Yang L; Pingel JT; Cheng TP; Schneeberger A; Yokoyama WM
    J Exp Med; 2008 Aug; 205(8):1829-41. PubMed ID: 18606857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation receptor-induced tolerance of mature NK cells in vivo requires signaling through the receptor and is reversible.
    Bolanos FD; Tripathy SK
    J Immunol; 2011 Mar; 186(5):2765-71. PubMed ID: 21263069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral infection transiently reverses activation receptor-mediated NK cell hyporesponsiveness in an MHC class I-independent mechanism.
    Mazumdar B; Bolanos FD; Tripathy SK
    Eur J Immunol; 2013 May; 43(5):1345-55. PubMed ID: 23440763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells.
    Voigt V; Forbes CA; Tonkin JN; Degli-Esposti MA; Smith HR; Yokoyama WM; Scalzo AA
    Proc Natl Acad Sci U S A; 2003 Nov; 100(23):13483-8. PubMed ID: 14597723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cells attenuate cytomegalovirus-induced hearing loss in mice.
    Almishaal AA; Mathur PD; Hillas E; Chen L; Zhang A; Yang J; Wang Y; Yokoyama WM; Firpo MA; Park AH
    PLoS Pathog; 2017 Aug; 13(8):e1006599. PubMed ID: 28859161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of a natural killer cell receptor family by a viral immunoevasin.
    Berry R; Ng N; Saunders PM; Vivian JP; Lin J; Deuss FA; Corbett AJ; Forbes CA; Widjaja JM; Sullivan LC; McAlister AD; Perugini MA; Call MJ; Scalzo AA; Degli-Esposti MA; Coudert JD; Beddoe T; Brooks AG; Rossjohn J
    Nat Immunol; 2013 Jul; 14(7):699-705. PubMed ID: 23666294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral MHC class I-like molecule allows evasion of NK cell effector responses in vivo.
    Pyzik M; Dumaine A; Charbonneau B; Fodil-Cornu N; Jonjic S; Vidal SM
    J Immunol; 2014 Dec; 193(12):6061-9. PubMed ID: 25392524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The complex of MCMV proteins and MHC class I evades NK cell control and drives the evolution of virus-specific activating Ly49 receptors.
    Železnjak J; Lisnić VJ; Popović B; Lisnić B; Babić M; Halenius A; L'Hernault A; Roviš TL; Hengel H; Erhard F; Redwood AJ; Vidal SM; Dölken L; Krmpotić A; Jonjić S
    J Exp Med; 2019 Aug; 216(8):1809-1827. PubMed ID: 31142589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cmv1-independent antiviral role of NK cells revealed in murine cytomegalovirus-infected New Zealand White mice.
    Rodriguez M; Sabastian P; Clark P; Brown MG
    J Immunol; 2004 Nov; 173(10):6312-8. PubMed ID: 15528370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymicrobial sepsis influences NK-cell-mediated immunity by diminishing NK-cell-intrinsic receptor-mediated effector responses to viral ligands or infections.
    Jensen IJ; Winborn CS; Fosdick MG; Shao P; Tremblay MM; Shan Q; Tripathy SK; Snyder CM; Xue HH; Griffith TS; Houtman JC; Badovinac VP
    PLoS Pathog; 2018 Oct; 14(10):e1007405. PubMed ID: 30379932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquisition of activation receptor ligand by trogocytosis renders NK cells hyporesponsive.
    Miner CA; Giri TK; Meyer CE; Shabsovich M; Tripathy SK
    J Immunol; 2015 Feb; 194(4):1945-53. PubMed ID: 25582853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.